Valuation Laboratorios Farmaceuticos Rovi, S.A. Wiener Boerse

Stocks

Real-time Estimate Tradegate Other stock markets 23:05:08 19/06/2026 +04			5-day change	1st Jan Change
57.92 ^EUR	-0.64%		+0.26%	-7.90%

05-13	Spanish stocks - Factors to watch on May 13	RE
05-09	Laboratorios Farmaceuticos Rovi, S.A., Q1 2026 Earnings Call, May 06, 2026

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	4,138	1,925	3,213	3,220	3,248	2,982	-	-
Change	-	-53.49%	66.93%	0.22%	0.87%	-8.19%	-	-
Enterprise Value (EV) ¹	4,112	1,872	3,251	3,305	3,272	2,959	2,891	2,781
Change	-	-54.48%	73.7%	1.65%	-1%	-9.55%	-2.3%	-3.84%
P/E	26.7x	9.67x	18.8x	23.6x	23.1x	22.3x	16.4x	13.8x
PBR	8.59x	3.71x	5.94x	5.63x	4.89x	3.94x	3.38x	2.89x
PEG	-	0.3x	-1.3x	-1.4x	7.71x	-4.55x	0.5x	0.7x
Capitalization / Revenue	6.38x	2.35x	3.87x	4.22x	4.37x	3.85x	3.27x	3.02x
EV / Revenue	6.34x	2.29x	3.92x	4.33x	4.4x	3.82x	3.17x	2.82x
EV / EBITDA	20.3x	6.72x	13.3x	15.9x	15.1x	14.5x	10.7x	8.78x
EV / EBIT	22.7x	7.32x	14.8x	18.4x	17.6x	17.2x	12.3x	9.91x
EV / FCF	37.9x	10.1x	54.3x	43.5x	27.4x	31.3x	23.2x	16.9x
FCF Yield	2.64%	9.95%	1.84%	2.3%	3.65%	3.19%	4.3%	5.93%
Dividend per Share ²	0.9556	1.294	1.104	0.9351	0.9594	0.9732	1.17	1.359
Rate of return	1.29%	3.59%	1.83%	1.49%	1.51%	1.67%	2.01%	2.33%
EPS ²	2.76	3.73	3.2	2.67	2.75	2.615	3.566	4.238
Distribution rate	34.6%	34.7%	34.5%	35%	34.9%	37.2%	32.8%	32.1%
Net sales ¹	648.7	817.7	829.5	763.7	743.5	774	913.1	986.9
EBITDA ¹	202.9	278.7	244.5	207.4	216.2	204.2	270.3	316.7
EBIT ¹	181.5	255.8	220.1	179.4	185.8	171.6	235.6	280.5
Net income ¹	153.1	199.7	170.3	136.9	140.4	133	182.6	217
Net Debt ¹	-25.87	-52.78	38.6	85.1	23.84	-22.53	-90.52	-201.4
Reference price ²	73.80	36.06	60.20	62.95	63.50	58.30	58.30	58.30
Nbr of stocks (in thousands)	56,069	53,375	53,370	51,149	51,149	51,149	-	-
Announcement Date	23/02/22	21/02/23	27/02/24	25/02/25	24/02/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	32.14x	11.69x	24.07x	0.62%	980B
JOHNSON & JOHNSON	24.41x	5.63x	15.32x	2.34%	550B
ABBVIE INC.	26.86x	6.49x	13.28x	3.17%	382B
ROCHE HOLDING AG	17x	4.23x	10.41x	3.14%	317B
ASTRAZENECA PLC	21.82x	4.57x	12.95x	1.92%	270B
NOVARTIS AG	20.35x	5.28x	12.82x	3.05%	269B
NOVO NORDISK A/S	12.43x	4.64x	9.55x	4.05%	191B
AMGEN INC.	21.95x	5.91x	10.33x	2.99%	182B
GILEAD SCIENCES, INC.	-44.34x	5.36x	29.54x	2.62%	154B
Average	14.73x	5.98x	15.36x	2.65%	366B
Weighted average by Cap.	21.70x	7.23x	16.87x	2.17%